Renovis and Pfizer Enter Substantial Agreement
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 61 (Table of Contents)
Published: 5 Jul-2005
DOI: 10.3833/pdr.v2005.i61.659 ISSN: 1756-7874
Section: General
Abstract
Renovis entered into a valuable agreement with Pfizer for R&D and commercialization of small molecules targeting vanilloid receptor VR1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018